Plastic surgery+tumor bed radiotherapy during surgery, so that women with breast cancer are still beautiful

In recent years, the incidence of breast cancer has increased year by year. According to the latest cancer data in 2020, breast cancer has exceeded lung cancer and has become the most new cases of cancer, which seriously threatens female patients' life and health. Surgical resection has always been the main method of breast cancer treatment. Traditional surgery needs to remove the entire breast. This not only causes patients to torture the pain, but also to withstand psychological pain, thereby losing confidence in life.

With the development of medical technology, the surgical method of breast cancer has changed from the previous destructive surgery to the current transformation of both treatment and beauty. Plastic surgery has become more and more beautiful women. The breast tumor center of Chongqing University's Cancer Hospital routinely carried out the radiotherapy of tumor bed during plastic surgery combined with plastic surgery. 1 radiotherapy during surgery can replace 5-8 local radiotherapy after surgery, greatly reducing the number of postoperative radiotherapy, reducing the local recurrence probability , Save the hospital for hospitalization and hospitalization.

During surgery, radiotherapy refers to a single large -dose accurate exposure to the tumor bed or potential sub -clinical lesions after surgical resection of the tumor or potential sub -clinical lesion, or for performed root treatment. Killing potential residual tumor cells, significantly reducing the risk of recurrence of tumor in situ, and improving the quality of survival of patients.

Ms. Qin, 44 years old, found that she had a mass of about 1 cm in the left breast during the physical examination of the unit. After a puncture examination, she was diagnosed with left milk infiltrated cancer. The clinical stage was CT1N0M01. The thought of might be to remove the entire breast, Ms. Qin could not accept it for a while. "Director Zeng, is there any way to keep my breasts?"

Faced with Ms. Qin's strong willingness to protect her milk, Zeng Xiaohua, director of the Breast Oncology Center, discussed the treatment team, and finally decided to implement tumor bed radiotherapy for Ms. Qin during plastic surgery. "Patients with early stages, good types, single lesions, tumors are far away from the center of areola.

"Radiation treatment needs to be performed for about one and a half months after conventional milk preservation, and the patient's treatment costs and psychological burden are invisibly increased." Director Zeng Xiaohua added, and tumor bed radiotherapy during plastic surgery was used. The number of radiotherapy, saving treatment time and cost, can better protect the normal tissue of the breast, so that the shape of the breast is better.

At 9 am on June 29, the operation was performed in a composite operating room. Zeng Xiaohua's team first performed biopsy for breast cancer outpost lymph nodes in accordance with conventional ways, and then expanded and removed the left milk clock, and the resection specimen was marked with a biopsy for freezing pathology.

After determining that the cutting edge and the base are negative, the tumor radiation therapy team began to perform precise radiotherapy on the tumor bed area. After 20 minutes, radiotherapy ends. Director Zeng Xiaohua subsequently applied plastic surgery technology to repair the local residual cavity of the breast, and sutured routinely after the restoration was completed. It took 2 and a half hours to the end, and the operation was successfully completed.

"Combining radiation therapy with milk -keeping surgery, and complete radiotherapy of breast gland in the surgical area before turning off the surgical incision, ensuring the accuracy of the positioning of the tumor bed and the accuracy of the radioactive dose. The probability of bed deviation reduces the local recurrence rate. At the same time, it can also avoid damage to important organs such as the heart, lungs, and esophagus, thereby reducing the occurrence of complications, "said Director Zeng Xiaohua.

Zeng Xiaohua

Director, chief physician, and master's tutor of the Breast Tumor Center of the Cancer Hospital of Chongqing University.

Chongqing has outstanding contributions to young and middle -aged experts. Member of the National Cancer Quality Control Center Breast Cancer Expert Committee, a member of the Breast Cancer Team of the Cancer Society of the Chinese Medical Association, and a member of the Breast Cancer Team of the Cancer Society of the Chinese Medical Doctors Association.

Outpatient time: Monday morning special clinic, every Monday afternoon special expert clinic, every Wednesday morning for outpatient clinics.

Chongqing University Affiliated Oncology Hospital

Introduction to Breast Oncology Center

The Breast Tumor Center of Chongqing University Affiliated Oncology Hospital was founded in the 1980s. It is a breast tumor characteristic specialist in the Chongqing Health and Health Commission, the Chongqing Breast Disease Treatment Center, and the Chongqing Breast Tumor Prevention Research Center. As one of the key departments of the hospital, there are currently 4 waters (2 surgery ward, 1 internal medicine, and 1 day diagnosis and treatment centers). 180 beds are prepared. , 6 vice high, 40 intermediate. There are 2 post -doctoral, 14 doctoral, 18 masters, 1 bloggers, and 4 masters.

The center has the most advanced breast specialist examination equipment, and conducts a variety of imaging combined positioning and guidance. Under the guidance of early diagnosis technology and precise individualized diagnosis and treatment methods. The comprehensive treatment of biological targets is characterized by the characteristics. In 1989, the early breast cancer retained breast surgery was carried out, and won the second prize of Chongqing Science and Technology Progress and the third prize of scientific and technological progress in Sichuan Province. In 2011, early breast cancer plastic surgery was carried out, which further improved the milk preservation rate. In 2020, the radiotherapy of plastic surgery (OPS) combined with the treatment of postoperative radiotherapy, saving treatment time and cost, and reducing the advantages of the number of postoperative radiotherapy, saving treatment time and expenses, and reducing it. The damage of the heart, lungs, esophagus and other organs has reduced the chance of complications and tumor recurrence, and has accumulated rich clinical experience. This center has gradually carried out the blood vessels in the lower abdominal wall since 2009, the blood vessels of the blood vessels (DIEP) breast reconstruction, TILOOP combined with prosthetic breast reconstruction, latissimus muscle skin flap combined with prosthetic breast reconstruction, latitone broadness Muscle flap (small incision or laparoscopy) rebuild breasts, lata muscle skin flaps repair chest wall defects, milk shrinkage and other technologies. The center dispatches the backbone of the center every year to the training and training of the authoritative plastic surgery hospital at home and abroad. The specialty diagnosis and treatment technologies of the specialty have become increasingly mature. Since 2019, two consecutive breast reconstruction training classes have been held. 900 breasts specialists have participated in training. highly recognition. In terms of academics, in the past ten years, this center has won 54 scientific research topics and published more than 183 academic papers, including SCI43 and 39 CSCD libraries. The discipline construction of the Health Commission is 1 million, and the national clinical key specialty construction is 1 million. Won 1 first prize and one third prize of the Chongqing Health and Health Commission Medical Achievement Award, and 1 second prize and third prize of Chongqing Science and Technology Award. Get 7 national invention patents. Editor -in -chief and editor -in -chief, participated in 6 diagnosis and treatment guidelines and expert consensus writing. Since the establishment of GCP full -time doctors in 2014, it has participated in more than 60 domestic and international multi -center clinical trial projects. The quality of the group has been well received, and as the team leader has started the national multi -center clinical trial.

- END -